日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma

抑制Spry1可降低HIF1α依赖性糖酵解并损害BRAF突变型皮肤黑色素瘤的血管生成

Montico, Barbara; Giurato, Giorgio; Guerrieri, Roberto; Colizzi, Francesca; Salvati, Annamaria; Nassa, Giovanni; Lamberti, Jessica; Memoli, Domenico; Sabatelli, Patrizia; Comelli, Marina; Bellazzo, Arianna; Fejza, Albina; Camicia, Lucrezia; Baboci, Lorena; Dal Bo, Michele; Covre, Alessia; Nyman, Tuula A; Weisz, Alessandro; Steffan, Agostino; Maio, Michele; Sigalotti, Luca; Mongiat, Maurizio; Andreuzzi, Eva; Fratta, Elisabetta

Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway

早期卵巢癌中发现的新型 BRCA2 新生变异揭示了一种独特的肿瘤演化途径

Miolo, Gianmaria; Canil, Giovanni; Polano, Maurizio; Dal Bo, Michele; Mondello, Alessia; Palumbo, Antonio; Puglisi, Fabio; Corona, Giuseppe

Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine

利用单克隆抗体靶向衰老标志:癌症免疫疗法和老年医学的新纪元

Dal Bo, Michele; Gambirasi, Marta; Vruzhaj, Idris; Cecchin, Erika; Pishdadian, Abbas; Toffoli, Giuseppe; Safa, Amin

Development of Clinical-Radiomics Nomogram for Predicting Post-Surgery Functional Improvement in High-Grade Glioma Patients

构建用于预测高级别胶质瘤患者术后功能改善的临床放射组学列线图

Ius, Tamara; Polano, Maurizio; Dal Bo, Michele; Bagatto, Daniele; Bertani, Valeria; Gentilini, Davide; Lombardi, Giuseppe; D'agostini, Serena; Skrap, Miran; Toffoli, Giuseppe

The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells

以抗糖蛋白聚糖1 AT101抗体作为靶向剂,可有效将壳聚糖纳米泡递送至胶质母细胞瘤细胞。

Di Cintio, Federica; Argenziano, Monica; Scomparin, Anna; Capolla, Sara; Busato, Davide; Steffè, Aharon; Mangogna, Alessandro; Sblattero, Daniele; Cavalli, Roberta; Macor, Paolo; Dal Bo, Michele; Toffoli, Giuseppe

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.

载有伊达比星的壳聚糖纳米泡可提高肝细胞癌患者的生存率并减少药物副作用

Mossenta Monica, Argenziano Monica, Capolla Sara, Busato Davide, Durigutto Paolo, Mangogna Alessandro, Polano Maurizio, Sblattero Daniele, Cavalli Roberta, Macor Paolo, Toffoli Giuseppe, Dal Bo Michele

CAR-T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View

CAR-T细胞在血液肿瘤和实体瘤治疗中的应用:从临床前到临床的视角

Capolla, Sara; Rasool, Maria; Toffoli, Giuseppe; Dal Bo, Michele

Molecular Characterization of Adult-Type Lower-Grade Glioma (WHO Grade 1-3) with Targeted Next-Generation Sequencing: A Retrospective, Single-Institution Experience

利用靶向二代测序技术对成人型低级别胶质瘤(WHO 1-3级)进行分子特征分析:一项回顾性单中心研究经验

Pinamonti, Maurizio; Polano, Maurizio; Cester, Giacomo; Saturno Spurio, Federico; Roman-Pognuz, Erik; Ukmar, Maja; Dal Bo, Michele; Zanconati, Fabrizio; Tacconi, Leonello; Meola, Antonio

Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model

用于靶向治疗的隐形工程化白蛋白包覆纳米颗粒:在异种移植斑马鱼模型中实现有效的药物递送和肿瘤抑制

Bozzer, Sara; Grimaldi, Maria Cristina; De Maso, Luca; Manfredi, Marcello; Toffoli, Giuseppe; Dal Bo, Michele; Sblattero, Daniele; Macor, Paolo

DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells

负载DNA的靶向纳米颗粒作为一种安全平台,可用于在肿瘤B细胞中生产外源蛋白。

Grimaldi, Maria Cristina; Bozzer, Sara; Sjöström, Dick J; Andersson, Linnea I; Mollnes, Tom Eirik; Nilsson, Per H; De Maso, Luca; Riccardi, Federico; Dal Bo, Michele; Sblattero, Daniele; Macor, Paolo